What is LABU?

LABU provides daily 3 times exposure to the S&P Biotechnology Select Industry Index.

PERFORMANCE [as of 03/22/23] 1 MONTH 3 MONTHS YTD 1 YEAR 3 YEARS 5 YEARS 10 YEARS
LABU -34.90% -37.66% -37.48% -74.02% -35.60% -44.89% --
LABU (NAV) -35.59% -12.14% -37.87% -64.30% -45.55% -44.56% --
S&P Biotechnology Select Industry Index -12.74% -12.16% -12.37% -20.99% 1.86% -4.07% 8.43%
N/A -- -- -- -- -- -- --
All returns over 1 year are annualized. All returns are total returns unless otherwise stated.

LABU Factset Analytics Insight

LABU is a daily 3x leveraged bet on an equal-weighted index of US biotech stocks. The vast majority of the fund's exposure is to biotechnology and medical research but also captures significant exposure to pharmaceuticals as well. As a leveraged product, the fund is not a buy-and-hold investment. It gets its leverage exposure through a portfolio of derivatives contracts that gets rebalanced at the end of each trading day. Because of that, the fund's return for periods longer than a day becomes path-dependent and is likely to be different from 3x the return of the index for the same period. This makes LABU suitable primarily for short-term traders. Over time, compounding effects can lead to profound differences in expected returns relative to the index.

LABU Summary Data

Direxion
05/28/15
1.01%
$841.51M
N/A
Open-Ended Fund

Peers

N/A
N/A

Fund Flows

-$0.02B 5 Days
+$0.30B 30 Days
-$0.18B 90 Days

LABU Fund Structure

Yes
Yes
-- / --
N/A
N/A
Low
3
Daily

LABU Tax Exposures

20.00% / 39.60%
--
No

LABU Portfolio Data

0.00%
N/A

LABU Index Data

Equal
Market Cap
N/A

Factset Analytics Block Liquidity

As of 03/23/23

This measurement shows how easy it is to trade a $1 million USD block of LABU. LABU is rated a 5 out of 5.

LABU Tradability

43,106,388
$297.56M
41,427,966
$285.13M
0.14%
$0.01
-0.03%
0.63% / -1.10%
None
100.00%
50,000
828.56
0.01%
--
275,302
$4.39
5